Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of PET/CT-Guided Biological Target Volume Delineation and Dose Optimization for Radioactive Seed Implantation Therapy in Malignant Tumors

NCT07327515 is registered in ClinicalTrials.gov with Li Min as lead sponsor.

NCT NCT07327515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07327515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of PET/CT-Guided Biological Target Volume Delineation and Dose Optimization for Radioactive Seed Implantation Therapy in Malignant Tumors
Lead sponsor
Li Min
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 31, 2026
Completion date
June 1, 2028
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant tumors